Get the Stockscreener App
4.41
0.28%
-0.0124
After Hours:
4.41
Neurometrix Inc stock is traded at $4.41, with a volume of 16,670.
It is down -0.28% in the last 24 hours and up +0.80% over the past month.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.
See More
Previous Close:
$4.4224
Open:
$4.4212
24h Volume:
16,670
Relative Volume:
1.41
Market Cap:
$9.05M
Revenue:
$5.27M
Net Income/Loss:
$-7.98M
P/E Ratio:
-0.741
EPS:
-5.9517
Net Cash Flow:
$-7.04M
1W Performance:
-0.45%
1M Performance:
+0.80%
6M Performance:
+6.56%
1Y Performance:
+12.89%
1-Day Range:
$4.375
$4.44
1-Week Range:
$4.375
$4.5004
52-Week Range:
$2.66
$4.73
Neurometrix Inc Stock (NURO) Company Profile
Name
Neurometrix Inc
Sector
Industry
Phone
(781) 890-9989
Address
1000 WINTER STREET, WALTHAM
Compare NURO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NURO
Neurometrix Inc
|
4.41 | 9.05M | 5.27M | -7.98M | -7.04M | -5.9517 |
|
ABT
Abbott Laboratories
|
124.44 | 215.82B | 41.95B | 13.40B | 6.35B | 7.65 |
|
SYK
Stryker Corp
|
345.80 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
BSX
Boston Scientific Corp
|
89.70 | 132.67B | 16.75B | 1.85B | 2.37B | 1.25 |
|
MDT
Medtronic Plc
|
82.88 | 106.28B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
69.36 | 40.63B | 5.72B | 4.17B | 259.90M | 6.97 |
Neurometrix Inc Stock (NURO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-17 | Reiterated | H.C. Wainwright | Buy |
| Jun-28-16 | Initiated | Rodman & Renshaw | Buy |
| Sep-11-15 | Initiated | Maxim Group | Buy |
| Feb-27-12 | Initiated | Dawson James | Buy |
Neurometrix Inc Stock (NURO) Latest News
NeuroMetrix, Inc. SEC 10-K Report - TradingView
StockNews.com Initiates Coverage on NeuroMetrix (NASDAQ:NURO) - Defense World
NeuroMetrix (NASDAQ:NURO) Stock Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
NeuroMetrix shareholders approve merger with electroCore By Investing.com - Investing.com Australia
NeuroMetrix shareholders approve merger with electroCore - Investing.com
Diabetic Neuropathic Pain Analysis Report 2025: Global - GlobeNewswire
NeuroMetrix (NASDAQ:NURO) Earns Sell Rating from Analysts at StockNews.com - Defense World
NeuroMetrix (NASDAQ:NURO) Share Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
NeuroMetrix (NASDAQ:NURO) Coverage Initiated at StockNews.com - Defense World
NeuroMetrix, Inc. to Host Earnings Call - ACCESS Newswire
NeuroMetrix (NASDAQ:NURO) Now Covered by StockNews.com - Defense World
NeuroMetrix (NASDAQ:NURO) Stock Crosses Above 200 Day Moving Average – Here’s Why - Armenian Reporter
NeuroMetrix (NASDAQ:NURO) Enters Into Asset Purchase Agreement with Fukuda Denshi Co., Ltd. - Defense World
NeuroMetrix (NASDAQ:NURO) Share Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
NeuroMetrix (NASDAQ:NURO) Share Price Crosses Above 200 Day Moving Average – Time to Sell? - Defense World
StockNews.com Begins Coverage on NeuroMetrix (NASDAQ:NURO) - Defense World
Muscle Stimulation Devices Market Overall Study Report - openPR
NEUROMETRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeuroMetrix, Inc.NURO - Business Wire
10 Best Diabetes Stocks To Buy Under $10 - Insider Monkey
Here’s Why NeuroMetrix, Inc. (NASDAQ:NURO) Is Among the Best Diabetes Stocks to Buy Under $10 - Insider Monkey
NeuroMetrix (NASDAQ:NURO) Announces Resignation of Board Member and Appointment of Replacement - Defense World
Neurometrix Announces Board Changes for 2024 - TipRanks
electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM (ECOR) - Seeking Alpha
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders - Longview News-Journal
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ZUO, BMTX on Behalf of Shareholders - The Eastern Progress Online
electroCore to acquire NeuroMetrix - Medical Buyer
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of NeuroMetrix, Inc.NURO - The Eastern Progress Online
Items Tagged with 'Dpncheck' - BioWorld Online
Electrocore powers up with Neurometrix acquisition - BioWorld Online
electroCore announces acquisition of Neurometrix - MSN
ElectroCore shares target increased, buy rating on NeuroMetrix deal By Investing.com - Investing.com Australia
ElectroCore shares target increased, buy rating on NeuroMetrix deal - Investing.com
electroCore to Acquire Neurotech Company NeuroMetrix - MPO-mag
Kuehn Law Encourages PWOD, NURO, BHLB, and BRKL Investors to Contact Law Firm - Finansavisen
electroCore to Acquire NeuroMetrix - citybiz
NURO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NeuroMetrix, Inc. Is Fair to Shareholders - The Bakersfield Californian
ElectroCore to Buy NeuroMetrix, Adding Quell Platform - MarketWatch
NeuroMetrix Merges with electroCore, Expands Quell Access - TipRanks
Electrocore to Acquire NeuroMetrix Enhancing Bioelectronic Offerings - TipRanks
NeuroMetrix to be Acquired by electroCore - The Manila Times
electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness - The Manila Times
Neurometrix Inc Stock (NURO) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):